Search Results - "Kruitwagen, R F M P"

Consecutive magnetic resonance imaging during brachytherapy for cervical carcinoma: predictive value of volume measurements with respect to persistent disease and prognosis by Mongula, J E, Slangen, B F M, Lambregts, D M J, Cellini, F, Bakers, F C H, Lutgens, L C H W, Van Gorp, T, Kruse, A J, Kruitwagen, R F P M, Beets-Tan, R G H

“…Cervical cancer is associated with a high yearly mortality. The presence of persistent disease after radiotherapy is a significant predictor of patient…”
Get full text

Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial by Koeneman, M M, Kruse, A J, Kooreman, L F S, Zur Hausen, A, Hopman, A H N, Sep, S J S, Van Gorp, T, Slangen, B F M, van Beekhuizen, H J, van de Sande, A J M, Gerestein, C G, Nijman, H W, Kruitwagen, R F P M

“…The "TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia" (TOPIC) trial was stopped preliminary, due to lagging inclusions. This study…”
Get full text

TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC trial): study protocol for a randomized controlled trial by Koeneman, M M, Kruse, A J, Kooreman, L F S, Zur Hausen, A, Hopman, A H N, Sep, S J S, Van Gorp, T, Slangen, B F M, van Beekhuizen, H J, van de Sande, M, Gerestein, C G, Nijman, H W, Kruitwagen, R F P M

“…Cervical intraepithelial neoplasia (CIN) is the premalignant condition of cervical cancer. Whereas not all high grade CIN lesions progress to cervical cancer,…”
Get full text

Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study by Mongula, J. E., Bakers, F. C. H., Vöö, S., Lutgens, L., van Gorp, T., Kruitwagen, R. F. P. M., Slangen, B. F. M.

“…Background Advanced stage cervical cancer is primarily treated by radiotherapy. Local tumor control is a prerequisite for cure. Imaging after treatment is…”
Get full text

Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era by You, Benoit, Van Wagensveld, Lilian, Tod, Michel, Sonke, Gabe S., Horlings, Hugo M., Kruitwagen, R. F. P. M., Du Bois, Andreas, Selle, Frédéric, Perren, Timothy, Pfisterer, Jacobus, Joly, Florence, Cook, Adrian, Kaminsky, Marie Christine, Wollschlaeger, Kerstin, Lortholary, Alain, Tome, Oliver, Leary, Alexandra, Freyer, Gilles, Van Der Aa, Maaike, Colomban, Olivier

“…Background In ovarian carcinomas, the likelihood of disease cure following first-line medical-surgical treatment has been poorly addressed. The objective was…”
Get full text

Outcomes of patients with early stage mucinous ovarian carcinoma: a Dutch population-based cohort study comparing expansile and infiltrative subtypes by Algera, Marc Daniël, Van de Vijver, Koen K, van Driel, Willemien J, Slangen, Brigitte F M, Lof, Fabienne C, van der Aa, Maaike, Kruitwagen, R F P M, Lok, Christianne A R

“…This study aimed to assess the outcomes of patients with early stage mucinous ovarian carcinoma based on subtype (expansile vs infiltrative). We…”
Get more information

Treatment preferences and involvement in treatment decision making of patients with endometrial cancer and clinicians by Kunneman, M, Pieterse, A H, Stiggelbout, A M, Nout, R A, Kamps, M, Lutgens, L C H W, Paulissen, J, Mattheussens, O J A, Kruitwagen, R F P M, Creutzberg, C L

“…Background: Vaginal brachytherapy (VBT) in high–intermediate-risk endometrial cancer (EC) provides a significant reduction in the risk of local cancer…”
Get full text

External validation of three prognostic models for overall survival in patients with advanced-stage epithelial ovarian cancer by van de Laar, R, IntHout, J, Van Gorp, T, Verdonschot, S, van Altena, A M, Gerestein, C G, Massuger, L F A G, Zusterzeel, P L M, Kruitwagen, R F P M

“…Background: For various malignancies, prognostic models have shown to be superior to traditional staging systems in predicting overall survival. The purpose of…”
Get full text

Reproductive and Hormonal Factors in Association With Ovarian Cancer in the Netherlands Cohort Study by Braem, M. G. M., Onland-Moret, N. C., van den Brandt, P. A., Goldbohm, R. A., Peeters, P. H. M., Kruitwagen, R. F. P. M., Schouten, L. J.

“…Parity, oral contraceptive use, and hysterectomy are known to protect against ovarian cancer, whereas the effect of other reproductive factors remains unclear…”
Get full text

Subjective assessment versus ultrasound models to diagnose ovarian cancer: A systematic review and meta-analysis by Meys, E.M.J, Kaijser, J, Kruitwagen, R.F.P.M, Slangen, B.F.M, Van Calster, B, Aertgeerts, B, Verbakel, J.Y, Timmerman, D, Van Gorp, T

“…Abstract Introduction Many national guidelines concerning the management of ovarian cancer currently advocate the risk of malignancy index (RMI) to…”
Get full text

No improvement in long-term survival for epithelial ovarian cancer patients: A population-based study between 1989 and 2014 in the Netherlands by Timmermans, M., Sonke, G.S., Van de Vijver, K.K., van der Aa, M.A., Kruitwagen, R.F.P.M.

“…This study investigates changes in therapy and long-term survival for patients with epithelial ovarian cancer (EOC) in the Netherlands. All patients with EOC,…”
Get full text

Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis by ten Broek, Richard P G, Issa, Yama, van Santbrink, Evert J P, Bouvy, Nicole D, Kruitwagen, Roy F P M, Jeekel, Johannes, Bakkum, Erica A, Rovers, Maroeska M, van Goor, Harry

“…Objective To estimate the disease burden of the most important complications of postoperative abdominal adhesions: small bowel obstruction, difficulties at…”
Get full text

Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods by Meys, E. M. J., Jeelof, L. S., Achten, N. M. J., Slangen, B. F. M., Lambrechts, S., Kruitwagen, R. F. P. M., Van Gorp, T.

“…ABSTRACT Objectives To validate externally the performance of the Assessment of Different NEoplasias in the adneXa (ADNEX) model and compare this model with…”
Get full text

Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study by Algera, M.D., Slangen, B.F.M., van Driel, W.J., Wouters, M.W.J.M., Kruitwagen, R.F.P.M.

“…Textbook outcome (TO) is a composite outcome measure used in surgical oncology to compare hospital outcomes using multiple quality indicators. This study aimed…”
Get full text

Local estrogen metabolism (intracrinology) in endometrial cancer: A systematic review by Cornel, K.M.C., Bongers, M.Y., Kruitwagen, R.P.F.M., Romano, A.

“…Endometrial cancer (EC) is the most common malignancy of the female gynaecological tract and increased exposure to estrogens is a risk factor. EC cells are…”
Get full text

Treatment and outcome of elderly patients with advanced stage ovarian cancer: A nationwide analysis by Schuurman, M.S., Kruitwagen, R.F.P.M., Portielje, J.E.A., Roes, E.M., Lemmens, V.E.P.P., van der Aa, M.A.

“…To provide an overview of treatment strategies for elderly patients with advanced stage epithelial ovarian cancer (EOC) in daily practice, evaluate changes…”
Get full text

The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery by Rutten, I.J.G, Ubachs, J, Kruitwagen, R.F.P.M, van Dijk, D.P.J, Beets-Tan, R.G.H, Massuger, L.F.A.G, Olde Damink, S.W.M, Van Gorp, T

“…Abstract Background Sarcopenia, severe skeletal muscle loss, has been identified as a prognostic factor in various malignancies. This study aims to investigate…”
Get full text

Effect of surgical volume on short-term outcomes of cytoreductive surgery for advanced-stage ovarian cancer: A population-based study from the Dutch Gynecological Oncology Audit by Algera, M.D., van Driel, W.J., Slangen, B.F.M., Wouters, M.W.J.M., Kruitwagen, R.F.P.M., Kruse, A.J., Yigit, R., Engelen, M.J.A., Nooij, L.S., Mens, J.W.M., de Jong, M.A.A., Haverkort, M.A.D., van der Aa, M., Diepstraten, J., van Ham, M.A.P.C., Smedts, H.P.M., Reesink, N., Gaarenstroom, K.N., Vencken, P.M.L.H., Boll, D., Fons, G., Baalbergen, A., van Dorst, E.B.L., Roes, E.M., Nagel, H.T.C., van Ginkel, A., de Waard, J., Hofman, L.N.

“…Despite lacking clinical data, the Dutch government is considering increasing the minimum annual surgical volume per center from twenty to fifty cytoreductive…”
Get full text

Overview of non-epithelial ovarian tumours: Incidence and survival in the Netherlands, 1989–2015 by van der Hel, O.L., Timmermans, M., van Altena, A.M., Kruitwagen, R.F.P.M., Slangen, B.F.M., Sonke, G.S., van de Vijver, K.K., van der Aa, M.A.

“…About 5% of ovarian tumours have a non-epithelial histology, including germ cell tumours (GCTs), sex cord-stromal tumours (SCSTs) and sarcomas. Because these…”
Get full text

Evaluation of various apparent diffusion coefficient measurement techniques in pre-operative staging of early cervical carcinoma by Mongula, J.E., Bakers, F., Slangen, B.F.M., van Kuijk, S.M.J., Kruitwagen, R.F.P.M., Mihl, C.

“…•ADC measurements are influenced by the used measurement technique.•Mean ADC values can reliable be measured with single ROI measurements.•Minimal and maximal…”
Get full text